Abstract Biologically active forms of vitamin D are important analytical targets in both research and clinical practice. The current technology is such that each of the vitamin D metabolites is usually analyzed by individual assay. However, current LC-MS technologies allow the simultaneous metabolic profiling of entire biochemical pathways. The impediment to the metabolic profiling of vitamin D metabolites is the low level of 1α,25-dihydroxyvitamin D 3 in human serum (15-60 pg/mL). Here, we demonstrate that liquid-liquid or solid-phase extraction of vitamin D metabolites in combination with Diels-Alder derivatization with the commercially available reagent 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) followed by ultra-performance liquid chromatography (UPLC)-electrospray/tandem mass spectrometry analysis provides rapid and simultaneous quantification of 1α,25-dihydroxyvitamin D 3 , 1α,25-dihydroxyvitamin D 2 , 24R,25-dihydroxyvitamin D 3 , 25-hydroxyvitamin D 3 and 25-hydroxyvitamin D 2 in 0.5 mL human serum at a lower limit of quantification of 25 pg/mL. Precision ranged from 1.6-4.8 % and 5-16 % for 25-hydroxyvitamin D 3 and 1α,25-dihydroxyvitamin D 3 , respectively, using solid-phase extraction.
Introduction
Metabolic profiling, defined here as the quantification of metabolites involved in the same metabolic pathway, has become an important tool for determining steady-state concentrations of metabolites and studying the regulation of the corresponding metabolic pathways [1, 2] . Metabolic profiling allows metabolic regulation to be surveyed in a minimally invasive manner using biofluids such as plasma or urine that are subsequently analyzed by GC-MS or LC-MS. The field of vitamin D metabolite analysis has been historically dominated by immunoassays and receptor binding assays [3] , although there are examples of the application of LC-UV or LC-MS to the analysis of 25-hydroxyvitamin D 2 (25(OH)D 2 ) and 25-hydroxyvitamin D 3 (25(OH)D 3 ) [4] [5] [6] . LC-MS can potentially detect and measure more than 40 reported vitamin D metabolites [7] . If we draw parallels with other families of steroid hormones, many of the vitamin D metabolites may have other biological roles beyond being mere catabolic products. However, very little is known about the biological roles of most of the downstream vitamin D metabolites, and the development of a comprehensive profiling method would facilitate research on vitamin D metabolism. Currently, most research and diagnostic assays focus on 25(OH)D and 1α,25-dihydroxyvitamin D (1α, 25(OH) 2 D) produced in a series of oxidations by the cytochromes P450 from their dietary precursor vitamin D (Fig. 1 ) [8] . Most current analytical methods based on immunoassays are not able to separate forms of vitamin D with different side-chains (mainly D 2 and D 3 ). There is a growing body of evidence that the biological activities of these forms may be different [9, 10] . This illustrates a need for analytical methods that are selective for D 2 and D 3 forms. Analytical methods for vitamin D also are needed for regulatory, quality control and nutritional studies. Biologically, the conversion of vitamin D 2 and D 3 into corresponding 25 (OH)D forms is rapid, as estimated from the 36-48-hour half-life of vitamin D 3 in human circulation [11] . Thus, there is usually little need to analyze the blood levels of vitamin D 2 and D 3 except supplementation studies. Subsequently, 25 (OH)D 3 is converted into biologically active 1α,25(OH) 2 D 3 , which binds to the vitamin D nuclear receptor (genomic response) as well as to a putative membrane receptor (rapid response) to initiate a cascade of biological events related to calcium and phosphorus homeostasis, cancer and inflammation [12] . Alternatively, 25(OH)D 3 is thought to be deactivated via conversion into 24R,25-dihydroxyvitamin D 3 (24R,25(OH) 2 D 3 ) by 25-hydroxyvitamin D 24-hydroxylase, although independent biological effects of 24R,25(OH) 2 D 3 are also known [13] [14] [15] . Furthermore, the same enzyme deactivates 1α,25(OH) 2 D 3 via conversion into 1α,24R,25-trihydroxyvitamin D 3 (1,24R,25(OH) 3 D 3 ). These metabolites can undergo further metabolism by several pathways including further oxidation and conjugation [8] .
The development of an LC-MS profiling method for vitamin D metabolites is impeded by their low concentration in human circulation, particularly for 1α,25(OH) 2 D 3 , with concentrations ranging from 15 to 60 pg/mL. Recently, an LC-tandem MS method was introduced to measure nonderivatized 1α,25(OH) 2 D 3 , but this requires 2 mL of human serum [16] . Vitamin D metabolites have low ionization efficiencies in electrospray (ESI) or atmospheric pressure chemical ionization (APCI) sources because they lack easily charged groups, which would enhance ionization efficiencies. However, the conjugated diene group of vitamin D metabolites makes them a specific target for Diels-Alder derivatization. In fact, several highly reactive 4-substituted 1,2,4-triazoline-3,5-diones (TADs or Cooksontype reagents) have been reported in the literature for the analysis of vitamin D metabolites, their analogs and other dienes, including derivatization reagents for ESI-MS [6, [17] [18] [19] [20] [21] [22] . The derivatization reagents introduce polar groups and thus typically result in a 100-1000-fold increase in sensitivity over nonderivatized compounds. However, no method for profiling the major vitamin D metabolites 1α,25(OH) 2 (Synthetica) were dissolved in acetonitrile to prepare stock solutions. The stock solutions were combined and diluted to obtain a 12.5 ng/mL d 6 1α,25(OH) 2 D 3 and 500 ng/mL d 6 25(OH)D 3 IS solution. The purity of the derivatized IS was assessed by LC-MS (full scan and MRM) up to 500 ng/mL and no interferences were found, including no traces of natural metabolites. All analytes were individually dissolved in a solution of PTAD (0.5 mg/mL) in acetonitrile at 100 ng/mL and allowed to react at room temperature for 4 h to form the corresponding PTAD Diels-Alder conjugate. No nonderivatized analytes were found in these solutions as analyzed by LC-MS (MRM). To prevent cross-contamination of the 1α,25 (OH) 2 D-PTAD calibration solution, it was prepared separately from the rest of the analytes. Using serial dilutions, 0.1, 0.3, 1.0, 3.0, and 10.0 ng/mL calibration stocks of 1α,25 (OH) 2 D 3 -PTAD and 1α,25(OH) 2 D 2 -PTAD were prepared. Similarly, we prepared calibration solutions of 25(OH)D 2 -PTAD and 25(OH)D 3 -PTAD at the levels of 0.1, 0.3, 1.0, 3.0, 10.0, 30.0, 100, 300 and 1000 ng/mL. These calibration solutions also contained 24R,25(OH) 2 D 3 -PTAD at tenfold lower levels than 25(OH)D 2 -PTAD and 25(OH)D 3 -PTAD; however, 0.01 and 0.03 ng/mL levels of 24R,25(OH) 2 D 3 were not used in practice.
Human samples
Plasma samples for the HIV study were obtained from the Reaching for Excellence in Adolescent Care and Health (REACH) repository [23, 24] . Serum samples from the sun exposure study were acquired from 17 volunteers in fall 2006 and 17 different volunteers in winter 2007 at week 0, week 4, and week 7 (week 8 in winter). Two 10-mL tubes of blood were collected from each participant after a fourhour fast from fat. The tubes were wrapped in foil and allowed to clot at room temperature for one hour. The tubes were centrifuged and then aliquoted in ten 1-mL tubes. These tubes were placed in light-proof boxes and kept frozen at −80°C. Commercial human serum from male donors (Fisher Scientific) was used for method development and validation except in the extraction reproducibility study, where donor plasma was used.
Sample pretreatment
Sample preparation was adapted from published methods [25] . Briefly, 500 μL aliquotes of human serum in 2 mL plastic tubes (Fisher Scientific) were spiked with 20 μL solution of internal standard (12.5 ng/mL d 6 1α,25-dihydroxyvitamin D 3 and 500 ng/mL d 6 25-hydroxyvitamin D 3 ) in acetonitrile and allowed to equilibrate for 15 min at room temperature. Proteins were precipitated by the addition of 500 μL acetonitrile and by spinning the sample on a Vortex mixer for 1 min at maximum speed followed by 10 min centrifugation at 10,000×g.
Liquid-liquid extraction
The supernatant from protein precipitation was transferred into 2-mL plastic tubes (Fisher Scientific) containing 400 μL 0.4 M K 2 HPO 4 and mixed using a Vortex mixer for 30 s followed by the addition of 500 μL methyl t-butyl ether (MTBE). The tubes were vigorously mixed for 2 min on a Vortex mixer, centrifuged for 5 min at 10,000×g, and the upper organic layer was transferred into 2-mL plastic tubes (Fisher Scientific). For method development, the organic extracts were spiked with 10 μL 25 ng/mL calcipotriol used as a control for derivatization efficiency. Samples were evaporated for 1 h using an RC10.22 vacuum concentrator (Jouan, Winchester, VA, USA), and 100 μL 0.75 mg/mL PTAD in acetonitrile was added to the residue followed by 1 min of mixing. Samples were left at room temperature for 1 h and then stored overnight at +4°C to allow the derivatization reaction to proceed to completion; then the samples were mixed for 30 s, centrifuged and transferred into 150-μL vial inserts.
Solid-phase extraction
Solid-phase extraction of vitamin D metabolites using Oasis HLB (Waters, Milford, MA, USA) sorbent was adopted from published methods [22, 25] . Oasis HLB cartridges (3 cc 60 mg) were preconditioned with 3 mL ethyl acetate, 3 mL methanol and 3 mL water. Individual valves of cartridges were closed after the water meniscus reached the sorbent surface. Cartridges were loaded with 900 μL supernatant from the protein precipitation protocol and 1 mL 0.4 M K 2 HPO 4 . The valves were opened and samples were extracted using gravity only. Cartridges were subsequently washed with 3 mL water and 2 mL of 70% methanol and dried for 2 min by application of negative pressure. The needles of the extraction manifold were wiped to remove residual solvent droplets. Samples were eluted with 1.5 mL of acetonitrile into 2 mL plastic tubes. For method development the organic extracts were spiked with 10 μL 25 ng/mL calcipotriol used as a control for derivatization efficiency. Samples were evaporated for 2.5 h using a vacuum concentrator (RC10.22) and 100 μL 0.75 mg/mL PTAD in acetonitrile was added to the residue followed by 1 min of vigorous mixing. Samples were left at room temperature for 1 h, stored overnight at +4°C for complete derivatization, vigorously mixed for 30 s, centrifuged and transferred into 150-μL vial inserts.
HPLC and tandem MS conditions
Separation was performed using an ACQUITY UPLC separation module (Waters). Samples were kept in the autosampler in amber glass vials at +10°C, and 10 μL samples were injected on the column. The UPLC BEH C18 2.1×100 mm 1.7 μm column (Waters) was kept at +40°C. Aqueous phase A consisted of 10 % v/v acetonitrile in water containing 0.1% formic acid as a modifier. Organic phase B was 100% methanol. Starting gradient conditions were 60% B at 0.4 mL/min flow rate. The following gradient program was used: 0-1 min 60% B; 7 min 72% B. After separation the column was washed with 100% B for 2 min, and equilibrated with 60% B for 2 min at a 0.4 mL/min flow rate. The Quattro Premier tandem mass spectrometer (Waters) was operated in positive electrospray mode with the capillary voltage set to 3.00 kV. Nitrogen gas flow rates were fixed with a cone gas flow of 25 L/h and a desolvation gas flow of 700 L/h. A source temperature of 125°C and a desolvation temperature of 350°C were applied. Argon was used as a collision gas at 2.2×10 −3 mbar. Other compound-specific settings are listed in , spike 2 (twofold spike 1) and spike 3 (fourfold spike 1). Samples were extracted and measured independently as described above.
Quantification and data analysis
Quantification was performed using a QuantLynx module of MassLynx 4.1 (Waters). Multi-point external calibrations with 1/x weighting were built for all endogenous analytes and one-point calibrations were made for deuterated analogs and calcipotriol. Calibration statistics are shown in Table 2 . Calcipotriol was added to ∼10% samples as a derivatization Fig. 2 . Moreover, while CID produces multiple fragments of native vitamin D metabolites, it produces a single major fragment for the derivatized products. The fragmentation patterns of native and derivatized 1α,25(OH) 2 D 3 are shown in Fig. 3 . This could also potentially be used to screen for additional vitamin D metabolites and other conjugated dienes using the precursor ion scan function. We also examined the stability of the derivatization reaction products. A test solution of derivatized analytes was prepared and stored for one week at −80°C, −20°C, +4°C and room temperature. No significant loss of the analytes was detected in samples stored at room temperature for one week compared to the samples stored at −80°C.
LC and MS optimization
Cone voltage and collision energies were optimized using injections of diluted standards. No sharp maxima were found and optimized parameters did not differ significantly in the range of ±5 V and ±3 V for cone voltage and collision energy, respectively (Table 1) . Both derivatized and nonderivatized vitamin D metabolites containing a hydroxyl group at position 25 easily lose water in the Z-spray source probably due to the formation of a stable tertiary carbocation. We observed similar dominant water loss in the QTRAP4000 Initially, acetonitrile with 0.1% formic acid was used as an organic phase for UPLC separation. However, we found that methanol without modifier gave the best signal intensity, probably due to its higher volatility [27] . Thus, methanol was used as the organic solvent despite a significantly higher backpressure. This demonstrates the additional advantage of using UPLC to improve the sensitivity of LC-MS. The target analytes were separated using gradient elution on a 10-cm BEH C18 UPLC column in 12 min, including column wash and re-equilibration ( Fig. 4 ; Table 2 ).
Derivatization of vitamin D metabolites with PTAD produces two epimers, 6S and 6R, corresponding to the position of the dienophile relative to the plane of the A ring. The major isomer peak was used for integration and quantification. We compared results for 25(OH)D 3 and 24R,25 (OH) 2 D 3 quantification in 50 individual serum samples using integration of either the major or minor peak and found a good correlation between the values (R 2 =0.9669 and R 2 =0.8838, respectively). The lower correlation for 24R,25(OH) 2 D 3 can be explained by the low intensity of the minor isomer peak and the lack of a corresponding isotopically labeled standard to correct the measurements. Interestingly, the C18 BEH UPLC stationary phase does not separate isomers of derivatized 1α,25(OH) 2 D 3 , probably due to the anti position of hydroxyl groups on its A ring, which make this structure more symmetric. Separation of derivatized 1α,25(OH) 2 D 3 can be achieved using phenyl BEH column chemistry, but this separation is not advanta- In addition to cycloaddition to the locked C-10-19 : C-5-6 cisoid diene, the Diels-Alder reaction can theoretically occur at the C-5-6 : C-7-8 diene if the C-6-C-7 bond rotates into a cisoid conformation. However, this reaction would be unfavorable because of the activation barrier to uncoupling the conjugated triene system and the steric hindrance to forming a planar diene. PTAD is not only a potent dienophile but also a mild oxidizing reagent. Therefore, other possible by-products of derivatization can be form because of the oxidation of secondary alcohols of vitamin D metabolites into corresponding ketones. We surveyed mass chromatograms of derivatized standards and did not find an abundant signal (>1% peak height of derivatized standard) that would correspond to keto-
Selectivity of the method was determined by surveying MRM chromatograms of the analytes extracted from human serum extracts. No significant interfering peaks were found for any of the analytes except 1α,25(OH)D 3 (Fig. 5) . The interference was present in both LLE and SPE human serum extracts. The interfering ion could not be suppressed with increasing quadrupole resolution because of concomitant 1α,25(OH) 2 D 3 -PTAD signal loss. The interfering ion is a product of serum matrix derivatization, because it was not found in nonderivatized serum matrix. It was not possible to use a different transition for the detection of 1α,25 (OH) 2 D 3 -PTAD, because the derivative only produces one dominant fragment ion, as shown above. The low signal intensity of the interfering peak did not allow the product and precursor MS/MS scan experiment to be performed. However, because the interfering compound coelutes with vitamin D metabolites under selective SPE conditions and undergoes Diels-Alder derivatization, we hypothesize that it is an unknown dihydroxyvitamin D 3 isomer with two hydroxyl groups on the A ring because of the characteristic m/z 314 fragment. A possible candidate metabolite is 1α,25-dihydroxy-3-epi-vitamin D 3 , a biologically active product of the catabolic epimerization of 1α,25(OH) 2 D 3 [28] . However, the lack of a commercially available standard does not allow this finding to be confirmed. Interestingly, 25-hydroxy-3-epi-vitamin D 3 was found as an interference in another LC-MS assay [29] . Thus, we used a 10-cm column to separate 1α,25(OH) 2 D 3 -PTAD from the interfering peak. It is crucial to use isotopically labeled 1α,25(OH) 2 D 3 to assign the correct retention time to this analyte. To increase the precision of quantification, we measured the height of the 1α,25(OH) 2 D 3 -PTAD peak while the area was measured for the quantification of other analytes (see "Electronic supplementary material").
Sample preparation
Initially, we used liquid-liquid extraction of vitamin D metabolites to demonstrate the feasibility of the method. Initial sample preparation steps such as protein precipitation with acetonitrile and subsequent dilution with 0.4 M K 2 HPO 4 were adopted from known methods of vitamin D extraction to fit the format of 2-mL polypropylene plastic tubes [25] . No losses of 1α,25(OH) 2 D 3 were detected with plastic tubes compared to borosilicate glass tubes (see "Electronic supplementary material"). We tested different modes of serum protein precipitation using acetonitrile, including fast and slow mixing and addition of the serum drop-wise to acetonitrile, and found no significant difference between them (see "Electronic supplementary material"). We also tested three different extraction solvents, MTBE, Fig. 4 Chromatographic separation of major vitamin D metabolites using the conditions described in the "Experimental" section dichloromethane and ethyl acetate, and found very similar extraction recoveries with the exception of dichloromethane, which produced lower recoveries for 25(OH)D 3 (Fig. 6) . Thus, we selected MTBE due to its low absorption of water, which deactivates PTAD, and its high volatility. To simplify sample preparation, one extraction step was performed subsequently.
The SPE method was adopted from the literature [22, 25] . The effects of SPE sample dilution, cartridge washing and elution solvents are shown in Fig. 7 . The resulting data correspond to standard guidance for vitamin D sample preparation, including sample dilution with 1 v. 0.4 M K 2 HPO 4 at pH 10.4 and cartridge washing with 70% methanol. Although a 30% methanol wash resulted in the highest recoveries of d 6 1α,25(OH) 2 D 3 , we selected 70% methanol wash as a standard procedure because samples obtained with <50% methanol wash contained a substantial amount of residual moisture that slows down sample concentration and may interfere with the yield of the derivatization reaction (Fig. 7b) . We found that an additional wash with hexane was not critical to sample preparation and thus omitted it to avoid forming a biphasic solution in SPE wastes. We selected acetonitrile as elution solvent because ethyl acetate and especially methanol negatively affected the yield of the derivatization reaction, as monitored with the derivatization control compound calcipotriol in the extraction matrix (Fig. 7c) . To elute residual analytes remaining on the cartridges after the first 1 mL of eluent, we increased the final elution volume to 1.5 mL.
The recoveries of the deuterated surrogates d 6 1α,25 (OH) 2 D 3 and d 6 25(OH)D 3 were determined in 25 individual human plasma samples extracted by optimized liquid-liquid extraction and 50 individual human serum samples extracted by optimized SPE (Table 3) . Because these recoveries also include the yield of the derivatization reaction, we spiked the organic extracts with the 1α,25(OH) 2 D 3 analog calcipotriol (calcipotriene) to determine the effect of the sample matrix on the derivatization yield. Compared with liquid-liquid extraction, SPE results in a lower derivatization yield but comparable extraction recoveries. The lower derivatization yield in SPE is probably due to traces of protic solvents (water and methanol) that deactivate PTAD while the low solubility of water in MTBE makes the LLE extracts the preferred matrix for the derivatization reagent. LLE and SPE give statistically the same results for vitamin D metabolites except for 24R,25(OH) 2 D 3 . These data were generated by extracting six aliquots of the same human plasma sample by SPE (n=3) and LLE (n=3) methods ( Reverse-phase SPE is known for its very high retention of vitamin D 2 and D 3 , which makes its application problematic. Only ∼30% of vitamin D 2 and D 3 are eluted from SPE cartridges under the conditions selected for our method (1.5 mL acetonitrile), as monitored by UPLC-UV. Using a stronger solvent such as ethyl acetate would decrease the purity of the sample and the yield of the derivatization reaction. Surprisingly, we found that LLE also results in poor recoveries of vitamin D 2 and D 3 . The addition of vitamin D 2 and D 3 standards to extracted serum matrix prior to derivatization revealed that the reason for the poor recoveries is a low derivatization reaction yield. However, poor recoveries were not obtained for other more polar forms of vitamin D. Taking into consideration the severe matrix effect present during the derivatization of vitamin D 2 and D 3 and the need for longer chromatographic runs, we omitted these analytes from the method.
Method validation
Calibration curves were linear over the entire range of selected concentrations (Table 2) . Because all analytes in the vitamin D pathways have similar structures and produce similar fragments in CID, we obtained relatively similar instrumental limits of detection (ILD) for all analytes. Instrumental limit of detection was determined as the lowest concentration in a series of dilutions that produces a chromatographic peak with a root mean square (RMS) signal-to-noise ≥ 3 under the standard chromatographic conditions of the method. Lower limits of quantification in plasma and serum were set to 25 pg/mL, estimated using the lowest calibration point of 100 pg/mL corrected for a sample dilution factor of 5 and 80% recovery (100/0.8/5). From the subsequent standard addition experiments we found that 1α,25(OH) 2 D 3 measurements above the LLOQ have precisions of <20% for both LLE and SPE (Tables 4 and 5 ). . a SPE cartridges were washed with 50 % methanol and eluted with 1.5 mL ethyl acetate. b SPE cartridges loaded with diluted supernatant were washed with 2 mL 70% methanol, 2 mL 50% methanol, 2 mL 50% methanol and 2 mL hexane, 2 mL 30% methanol, and water and eluted with 1.5 mL ethyl acetate. c SPE cartridges were loaded with diluted supernatant, washed with 70% methanol and eluted from Oasis HLB cartridges with 3×1 mL of acetonitrile (MeCN), ethyl acetate (EtAc) or methanol (MeOH). Each 1 mL sample was spiked with calcipotriol to study the effect of matrix on derivatization efficiency. Four samples were analyzed independently in each sample group (black bars, d 6 1α,25(OH) 2 D 3 ; gray bars, d 6 25(OH)D 3 ; white bars, calcipotriol). All serum samples were spiked with deuterated surrogates prior to sample preparation. Error bars represent standard deviations The lowest calibration point (100 pg/mL) for all analytes produced chromatographic peaks with RMS signal to noise > 10. Because vitamin D metabolites are endogenous compounds, we studied method accuracy and precision using the addition of known quantities of vitamin D metabolites to human serum and extracted it by LLE and SPE. Separate standard addition experiments were performed for samples extracted by LLE (Table 4) and SPE ( 3 . The differences in metabolite concentrations in native serum between LLE and SPE experiments are due to the different batches of pooled human serum used in the experiments. We set quality control criteria for all extractions as precision (RSD) <20% and accuracy (analyte recovery corrected to the recovery of a corresponding deuterated internal standard) in the range of 75-125%. All samples passed these criteria except 1α,25(OH) 2 D 3 measurement in native serum after SPE, which was below the LLOQ and above the 20% precision criterion. Average accuracies in the spiked samples were 99.6% for 25(OH)D 3 and 111% for 1α,25(OH) 2 In addition, 50 individual human serum samples were analyzed with a 25(OH)D RIA (Diasorin). We found a good correlation between LC-MS and RIA data (Fig. 8) . However, the results from the LC-MS method were systematically higher than the RIA 25(OH)D results. Both methods of 25(OH)D analysis were validated by the analysis of DEQAS samples [26] and found to give results within the desirable inter-laboratory mean (±σ). Interestingly, other LC-MS methods of 25(OH)D analysis in DEQAS studies tend to produce systematically higher measurements than RIA methods (data not shown). This LC-MS bias might be a Concentration (accuracy (analyte recovery corrected to recovery of corresponding deuterated internal standard) ± precision (RSD)) b Quantity added to 0.4 mL serum prior to protein precipitation and extraction 
Biological applications
Photosynthesis of vitamin D is a route parallel to dietary supplementation in humans (Fig. 1) . UV light (290-315 nm) induces cleavage of the C-9-C-10 bond of 7-dehydrocholesterol with subsequent proton migration and conformational changes producing vitamin D 3 . For example, one minimal erythemal dose of UV exposure from sunlight resulted in the production of 10,000-20,000 IU (0.25-0.5 mg) of vitamin D 3 [30] . Typically, vitamin D photosynthesis in skin is thought to satisfy most human dietary requirements. However, the photosynthesis of vitamin D 3 in skin becomes less efficient in people with darker skin living in higher latitudes, where sun exposure is insufficient to generate enough vitamin D 3 , or alternatively in people with mostly indoor lifestyles and those who habitually use
sunscreens. An LC-MS method specific for D 3 forms of vitamin D is particularly useful for studies of the photosynthesis of vitamin D 3 in skin because it avoids interference with D 2 metabolites from the diet. Because the major aim of our method development was to study the effect of skin pigmentation on vitamin D, we used a LLE version of the method to study the vitamin D deficiency in an HIVpositive urban Afro-American population previously reported to be 25(OH)D-deficient. The SPE version of the method was used for high-throughput phenotyping of vitamin D metabolism in subjects with different levels of sun exposure and different levels of skin pigmentation. The occurrence of D 2 group metabolites was sporadic in studied groups and was therefore omitted from the discussion.
Effect of HIV infection on vitamin D profile
As a pilot study we analyzed eight plasma samples from HIV-negative females and compared their vitamin D profile with the vitamin D profile in seven plasma samples of HIV-positive females. The samples were acquired from the REACH depository [23, 24] . We found good agreement with previously acquired immunoassay data on their 25 (OH)D status, showing that both groups are vitamin Ddeficient (25(OH)D < 32 ng/mL), with no statistical difference between the groups (Fig. 9) [38] , sarcoidosis [39] and tuberculosis [40] .
Seasonal variations in vitamin D metabolites
We analyzed 102 individual serum samples acquired from 34 subjects with different levels of sun exposure and different levels of skin pigmentation. The preliminary data showed that the majority of the studied population had a very low level of 25(OH)D 2 (< 3.0 ng/mL), which corresponds to the fact that the diet is supplemented predominantly with the D 3 form. However, in three of the 34 subjects the level of 25(OH)D 2 was high (16.6, 9.2, and 6.3 ng/mL measured as the average of three time points [9, 10] . In addition, in contrast to vitamin D 3 , which can be produced by photosynthesis in vivo, vitamin D 2 is adsorbed solely from the diet (Fig. 1) . Thus, separate measurement of the D 2 and D 3 forms of vitamin D is especially valuable for studying the photosynthesis of this vitamin. As expected from the seasonal variation in sun exposure, there was a significant difference in 25(OH)D 3 levels between the fall and winter study groups (Fig. 10) (Fig. 1) . However, if 25(OH)D 3 status is sufficient (>32 ng/mL), as in the fall study group, the production of 1α,25(OH) 2 
